Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data

Thread starter U.S. News
Start date Aug 19, 2025

U.S. News

Guest

Aug 19, 2025

The results could reinforce Eli Lilly and Novo Nordisk's dominance in the booming market for weight loss and diabetes drugs.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data

Prefix: N/A

Forum: USA News

Start date: Aug 19, 2025

Last reply date: Aug 19, 2025

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Aug 19, 2025

Replies: 0

Views: 17

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search